BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that the underwriters of its previously announced public offering of common stock have exercised in full their over-allotment option to purchase an additional 1,756,097 shares of common stock. Including this option exercise, total gross proceeds from the offering of an aggregate of 13,463,415 shares at a price to the public of $41.00 per share will be approximately $552 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on September 16, 2015, subject to customary closing conditions.
Help employers find you! Check out all the jobs and post your resume.
